US Patent

US12070629 — Core stabilized microcapsules, method of their preparation and uses thereof

Method of Use · Assigned to Sol Gel Technologies Ltd · Expires 2030-12-30 · 5y remaining

Vulnerability score 81/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects a method of using core-stabilized microcapsules that contain at least one active agent encapsulated within an inorganic oxide shell.

USPTO Abstract

The present invention provides core-stabilized microcapsules, wherein said core comprises at least one active agent encapsulated within an inorganic oxide shell, processes for their preparations, comparisons comprising them and uses thereof.

Drugs covered by this patent

Benzamycin (BENZOYL PEROXIDE) · Mayne Pharma

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-3987`	—	Benzamycin

Patent Metadata

Patent number: US12070629
Jurisdiction: US
Classification: Method of Use
Expires: 2030-12-30
Drug substance claim: No
Drug product claim: Yes
Assignee: Sol Gel Technologies Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.